Profile
Bure Equity is a private equity firm based in Stockholm, Sweden, founded in 1992. The firm emerged from the dismantled employee funds and was listed on Nasdaq Stockholm in 1993. Bure Equity is known for its active engagement with portfolio companies, leveraging its expertise across various industries to foster strategic development and growth.
The firm invests primarily in the engineering, pharmaceuticals, life sciences, and manufacturing sectors. Bure Equity typically engages in buyout and growth/expansion investments, focusing on companies in Europe. The firm has a team of eight professionals and maintains a portfolio of 13 companies, with a history of 94 investments and 48 exits.
Notable investments by Bure Equity include Silex Microsystems - general purpose semiconductors, Mentimeter - business/productivity software, and Xvivo Perfusion - medical supplies. The firm has also invested in Sistematica and Mycronic, showcasing its diverse investment portfolio.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.